Han M G, Wang Q, Smiley J R, Chang K O, Saif L J
Food Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, 1680 Madison Ave., Wooster, OH 44691, USA.
J Clin Microbiol. 2005 Feb;43(2):778-85. doi: 10.1128/JCM.43.2.778-785.2005.
None of the enteric caliciviruses except Po/Sapo/GIII/Cowden/80/US replicates in cell culture, which complicates efforts to develop control strategies or to study viral replication. To develop serological assays for bovine noroviruses (BoNVs) and to determine the cross-reactivity of BoNV with human noroviruses, we generated two recombinant baculoviruses, rCV186-OH and rJNCV, to express the capsid genes of Bo/CV186-OH/00/US (Norovirus genogroup III [GIII], genotype 2 [GIII/2]). rCV186-OH expressed the expected 57-kDa capsid protein, but rJNCV expressed a truncated capsid protein of 35 kDa. Sequence analysis of rJNCV identified a single nucleotide deletion in the P domain of the capsid gene, which introduced a stop codon at amino acid 323. The recombinant capsid protein produced by rCV186-OH but not that produced by rJNCV self-assembled into virus-like particles (VLPs) similar to native BoNV. An antibody-capture enzyme-linked immunosorbent assay (ELISA) and antigen-capture ELISA (Ag-ELISA) detected serum antibody and antigen, respectively, from calves infected with Bo/CV186-OH/00/US but not antibodies or antigens to other enteric viruses. In other tests of the GIII/2 BoNV Ag-ELISA, no cross-reactivity was observed with VLPs from one GI and four GII human noroviruses and porcine sapovirus Cowden strain. Because, like human noroviruses, BoNVs do not grow in cell culture, the BoNV VLPs will be useful in the serological assays described for the detection of BoNV antibody and antigen. Consistent with the phylogenetic analysis of the capsid genes of bovine and human noroviruses (M. G. Han, J. R. Smiley, C. Thomas, and L. J. Saif, J. Clin. Microbiol. 42:5214-5224, 2004), the results suggest that GIII/2 BoNV does not share significant antigenic relationships with the five characterized human noroviruses tested.
除了Po/Sapo/GIII/Cowden/80/US之外,肠道杯状病毒均无法在细胞培养物中复制,这使得开发控制策略或研究病毒复制变得复杂。为了开发针对牛诺如病毒(BoNVs)的血清学检测方法,并确定BoNV与人类诺如病毒的交叉反应性,我们构建了两种重组杆状病毒,rCV186-OH和rJNCV,用于表达Bo/CV186-OH/00/US(诺如病毒基因组III [GIII],基因型2 [GIII/2])的衣壳基因。rCV186-OH表达了预期的57 kDa衣壳蛋白,但rJNCV表达了一种35 kDa的截短衣壳蛋白。对rJNCV的序列分析表明,衣壳基因的P结构域存在单个核苷酸缺失,导致在氨基酸323处引入了一个终止密码子。rCV186-OH产生的重组衣壳蛋白能够自组装成类似于天然BoNV的病毒样颗粒(VLP),而rJNCV产生的则不能。抗体捕获酶联免疫吸附测定(ELISA)和抗原捕获ELISA(Ag-ELISA)分别检测到感染Bo/CV186-OH/00/US的小牛血清中的抗体和抗原,但未检测到针对其他肠道病毒的抗体或抗原。在对GIII/2 BoNV Ag-ELISA的其他测试中,未观察到与一株GI和四株GII人类诺如病毒以及猪杯状病毒考登株的VLP有交叉反应。由于与人类诺如病毒一样,BoNVs无法在细胞培养物中生长,因此BoNV VLP将有助于上述用于检测BoNV抗体和抗原的血清学检测。与牛和人类诺如病毒衣壳基因的系统发育分析结果一致(M. G. Han、J. R. Smiley、C. Thomas和L. J. Saif,《临床微生物学杂志》42:5214-5224,2004年),结果表明GIII/2 BoNV与所测试的五种已鉴定的人类诺如病毒没有显著的抗原关系。